אנלוג של GLP2 לטיפול ב- SBS במתן אוראלי יוצג בכנס ESPEN2025.
false
אופקו הלת', אינק
2
380
OPKO HEALTH, INC
Corporation no:
2279206
13156
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
08/07/2025
www.isa.gov.il
www.tase.co.il
Reference:
2025-02-050325
Time of broadcast:
15:01
15:01
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
אנלוג של GLP2 לטיפול ב- SBS במתן אוראלי יוצג בכנס ESPEN2025.
20250708PR_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ GSM
Date of revision of form structure:
06/08/2024
Address:
Ashlegan
16
,
Kiryat Gat
8211804
Israel
,
Tel:
08-9300051
,
Fax:
08-9543101
E-mail address:
gfaibish@opko.com
Company site:
Www.Opko.Com
Previous names of reporting entity:
Name of the Signatory:
Faibish Gabriel
Position of Signatory in the reporting corporation:
General Counsel
Name of Employer Company:
Address:
Ashlegan
16
,
Kiryat Gat
8211804
Telephone:
08-9300051
Facsimile:
08-9543101
E-mail:
gfaibish@opko.com
1